Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New formulation of Zofran receives marketing clearance in the U.S.

Feb. 15, 1999

Mitsubishi antidepressant to be codeveloped by Taisho

Feb. 12, 1999

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

Astra describes N-type neuronal calcium channel blockers and their use

Feb. 12, 1999

Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.

Feb. 12, 1999

OT-7100, a novel analgesic compound for the treatment of peripheral neuropathic pain

Feb. 11, 1999

Potassium channel modulators claimed for dementia by Bayer

Feb. 11, 1999

RPR and Targacept enter agreement to develop AD and PD treatments

Feb. 11, 1999

Inadvertent overdoses of Cerebyx due to labeling confusion lead to death

Feb. 10, 1999

Effects of NS-105 on cAMP production involve different mGluR groups

Feb. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...